Nilotinib Exerts Direct Effects on Vascular Endothelial Cells and May Act As a Co-Trigger of Atherosclerosis in Patients with Ph plus CML

被引：0
|
作者：
Hadzijusufovic, Emir [1 ]
Herndlhofer, Susanne [1 ]
Aichberger, Karl J. [1 ]
Ghanim, Viviane [1 ]
Suppan, Verena [1 ]
Cerny-Reiterer, Sabine [1 ]
Sperr, Wolfgang R. [1 ]
Valent, Peter [1 ]
机构：
[1] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1183 / 1184
页数：2
相关论文
共 8 条
  • [1] Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CML
    Hadzijusufovic, E.
    Albrecht-Schgoer, K.
    Huber, K.
    Grebien, F.
    Eisenwort, G.
    Schgoer, W.
    Ghanim, V
    Sadovnik, I
    Kaun, C.
    Herndlhofer, S.
    Theurl, M.
    Cerny-Reiterer, S.
    Hoermann, G.
    Jilma, B.
    Sperr, W. R.
    Rix, U.
    Wojta, J.
    Wolf, D.
    Superti-Furga, G.
    Kirchmair, R.
    Valent, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 300 - 300
  • [2] Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML
    Emir, Hadzijusufovic
    Albrecht-Schgoer, Karin
    Huber, Kilian
    Grebien, Florian
    Eisenwort, Gregor
    Schgoer, Wilfried
    Kaun, Christoph
    Herndlhofer, Susanne
    Theurl, Markus
    Cerny-Reiterer, Sabine
    Hoermann, Gregor
    Sperr, Wolfgang R.
    Uwe, Rix
    Wojta, Johann
    Wolf, Dominik
    Superti-Furga, Giulio
    Kirchmair, Rudolf
    Valent, Peter
    BLOOD, 2013, 122 (21)
  • [3] Ponatinib Exerts Multiple Effects on Vascular Endothelial Cells: Possible Mechanisms and Explanations for the Adverse Vascular Events Seen in CML Patients Treated with Ponatinib
    Hadzijusufovic, Emir
    Kirchmair, Rudolf
    Theurl, Markus
    Gamperl, Susanne
    Lener, Daniela
    Gutmann, Clemens
    Stanzl, Ursula
    Kirsch, Andrijana
    Frank, Sasa
    Valent, Peter
    BLOOD, 2016, 128 (22)
  • [4] PRO-ATHEROGENIC AND ANTI-ANGIOGENIC EFFECTS OF NILOTINIB ON ENDOTHELIAL CELLS: A POTENTIAL MECHANISM TO EXPLAIN VASCULOPATHIES IN CML PATIENTS TREATED WITH NILOTINIB
    Hadzijusufovic, E.
    Albrecht-Schgoer, K.
    Huber, K.
    Grebien, F.
    Eisenwort, G.
    Schgoer, W.
    Ghanim, V.
    Kaun, C.
    Herndlhofer, S.
    Theurl, M.
    Cerny-Reiterer, S.
    Sadovnik, I.
    Hoermann, G.
    Jilma, B.
    Sperr, W. R.
    Rix, U.
    Wojta, J.
    Wolf, D.
    Superti-Furga, G.
    Kirchmair, R.
    Valent, P.
    HAEMATOLOGICA, 2014, 99 : 510 - 510
  • [5] Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome plus CML
    Hadzijusufovic, Emir
    Albrecht-Schgoer, Karin
    Huber, Kilian
    Grebien, Florian
    Eisenwort, Gregor
    Schgoer, Wilfried
    Kaun, Christoph
    Herndlhofer, Susanne
    Theurl, Markus
    Cerny-Reiterer, Sabine
    Hoermann, Gregor
    Sperr, Wolfgang R.
    Rix, Uwe
    Sadovnik, Irina
    Jilma, Bernd
    Schernthaner, Gerit Holger
    Wojta, Johann
    Wolf, Dominik
    Superti-Furga, Giulio
    Kirchmair, Rudolf
    Valent, Peter
    BLOOD, 2014, 124 (21)
  • [6] A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment
    Esposito, Nicola
    Colavita, Irene
    Quarantelli, Fabrizio
    Izzo, Barbara
    Luciano, Luigia
    Del Vecchio, Luigi
    Hughes, Timothy
    Radich, Jerald
    Russo, Domenico
    Soverini, Simona
    Iacobucci, Ilaria
    Martinelli, Giovanni
    Saglio, Giuseppe
    Melo, Junia
    Ruoppolo, Margherita
    Kalebic, Thea
    Pane, Fabrizio
    BLOOD, 2008, 112 (11) : 1093 - 1093
  • [7] Successful preservation of BCR-ABL1 protein and direct measure of kinase activity in peripheral blood of CML and Ph plus ALL patients unveil a kinase inhibitory activity present in CML cells
    Boni, Christian
    Bonifacio, Massimiliano
    Vezzalini, Marzia
    Scaffidi, Luigi
    Tomasello, Luisa
    Krampera, Mauro
    Sorio, Claudio
    FASEB JOURNAL, 2021, 35
  • [8] Down-modulation of shp1 and hsp70 provides a survival advantage to the ph plus cells of CML patients additive to that related to the oncogenic BCR/ABL protein and may account for resistance to Ima treatment
    Esposito, Nicola
    Quarantelli, Fabrizio
    Izzo, Barbara
    Casadei, Giada Muccioli
    Luciano, Luigia
    Saglio, Giuseppe
    Melo, Junia V.
    Kalebic, Thea
    Martinelli, Giovanni
    Pane, Fabrizio
    BLOOD, 2007, 110 (11) : 307A - 307A
1